111, Inc. Sponsored ADR Class A (YI.US) Southwest Operations Center Chongqing Yihao has been crowned "Top 100 Service Industry Enterprises in Chongqing" for three consecutive years.
Recently, Chongqing officially released the "Top 100 Service Industry Enterprises" list for 2025. 1 (YI.US)'s subsidiary, Chongqing Yihao Pharmaceutical Co., Ltd., has made the list for the third consecutive year thanks to its outstanding operational strength and sustained innovative growth, showcasing its leading position and profound accumulation in the pharmaceutical circulation field.
Recently, Chongqing officially released the list of the top 100 service industry enterprises in 2025. Chongqing Yihao Pharmaceutical Co., Ltd., a subsidiary of 111, Inc. Sponsored ADR Class A (YI.US), has been honored on the list for the third consecutive year due to its outstanding operational strength and sustained innovation growth, demonstrating its leading position and profound accumulation in the pharmaceutical distribution field.
Established in the Liangjiang New Area of Chongqing in 2018, Chongqing Yihao has become an important strategic layout of 111, Inc. Sponsored ADR Class A in the southwestern region. It has developed into a modern pharmaceutical distribution enterprise integrating drug, medical equipment, and health food wholesale, with a business category of more than 200,000. The company, based on large-scale intelligent warehousing, has deeply integrated the core capabilities of 111, Inc. Sponsored ADR Class A in intelligent supply chain, digital marketing, and user management to build a digitalized marketing platform for pharmaceuticals.
With the long-term support of governments at all levels in Chongqing and the Liangjiang New Area, Chongqing Yihao has achieved rapid development since its establishment. By 2024, the company's annual revenue had reached 2.9 billion RMB, and it had built a modern professional drug warehouse covering over 25,000 square meters, providing solid guarantees for efficient operation.
Currently, Chongqing Yihao's business covers over 500,000 pharmacies nationwide, accounting for more than 90% of the total number of pharmacies in China. Through the digital platform "1 Drug City" created by 111, Inc. Sponsored ADR Class A Group, downstream physical pharmacies can conveniently purchase a variety of drugs nationwide, enjoy more competitive purchase prices, and one-stop sourcing services; upstream pharmaceutical companies rely on its efficient supply chain network to quickly distribute products to the national market, achieving efficient delivery within 24 hours to 890 counties and cities.
As the southwest operation hub of 111, Inc. Sponsored ADR Class A Group, Chongqing Yihao is continuously integrating regional pharmaceutical industry resources to accelerate the promotion of high-quality pharmaceutical products to the national market, supporting the implementation of the "Healthy China" strategy.
Established in 2010, 111, Inc. Sponsored ADR Class A has formed a comprehensive medical health system, including online retail pharmacy "111, Inc. Sponsored ADR Class A", self-operated offline pharmacies, online medical management service "1 Health", digital pharmaceutical distribution service "1 Drug City", and SaaS-based core service "1 Start Health".
Currently, 111, Inc. Sponsored ADR Class A has established strategic cooperation with over 500 domestic and foreign pharmaceutical companies. Its "1 Drug City" covers more than 500,000 individual and small to medium-sized chain pharmacies nationwide, accounting for 90% of the total number of pharmacies in China. On September 12, 2018, 111, Inc. Sponsored ADR Class A was listed on the NASDAQ stock exchange in the United States under the ticker symbol "YI", becoming the first Chinese internet medical health company to go public in the US.
Related Articles

WANT WANT CHINA (00151) announces mid-year results. The company's equity holders' share of profit is approximately 1.717 billion yuan, a decrease of 7.8% year-on-year.

Merck & Co., Inc. (MRK.US) urges shareholders to reject Tutanota's discounted "mini equity" acquisition offer.

HK Stock Market Move | YEAHKA (09923) increased by over 5%, with a 50% increase in transaction volume of overseas payment business in the third quarter.
WANT WANT CHINA (00151) announces mid-year results. The company's equity holders' share of profit is approximately 1.717 billion yuan, a decrease of 7.8% year-on-year.

Merck & Co., Inc. (MRK.US) urges shareholders to reject Tutanota's discounted "mini equity" acquisition offer.

HK Stock Market Move | YEAHKA (09923) increased by over 5%, with a 50% increase in transaction volume of overseas payment business in the third quarter.






